The material offers improved tolerance to harsh biological conditions while maintaining softness, resilience, and integration.
The company’s model recovers and recycles eligible medical plastics and materials following sterilisation.
The company will move into an 88,00-square-foot facility.
The company’s customers will benefit from a significantly increased cleanroom capacity.
The move will expand the company’s medical device design and manufacturing platform.
The company helps to bring life science developers’ products to market.
The company will be demonstrating how precision micro moulding can support drug delivery and pharmaceutical packaging of the future.
The prediction is based on the NHS’s growing demand for more sustainable supply chains.
The medical device manufacturer will exhibit five key technologies at the events.
The biofilm was found to bind and expel up to 98% of microplastics from the digestive system.
Thornbury Manufacturing Limited (TML), one of Wittmann UK’s long-term customers, continues to thrive amid 2025’s difficult trading headwinds and uncertain UK Government commitment to manufacturers.
He will oversee quality, operations, design, and engineering, while also being responsible for the company’s performance.
